Related Experiment Video
Updated: May 24, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Identification of a target cell permissive factor required for contact-dependent growth inhibition (CDI)
Elie J Diner1, Christina M Beck, Julia S Webb
1Department of Molecular, Cellular, and Developmental Biology, University of California at Santa Barbara, CA 93106, USA.
Abstract:
Bacterial contact-dependent growth inhibition (CDI) is mediated by the CdiB/CdiA family of two-partner secretion proteins. CdiA effector proteins are exported onto the surface of CDI(+) inhibitor cells, where they interact with susceptible bacteria and deliver effectors/toxins derived from their C-terminal regions (CdiA-CT). CDI(+) cells also produce an immunity protein that binds the CdiA-CT and blocks its activity to prevent autoinhibition. Here, we show that the CdiA-CT from uropathogenic Escherichia coli strain 536 (UPEC536) is a latent tRNase that requires activation by the biosynthetic enzyme CysK (O-acetylserine sulfhydrylase A). UPEC536 CdiA-CT exhibits no nuclease activity in vitro, but cleaves within transfer RNA (tRNA) anti-codon loops when purified CysK is added. CysK and CdiA-CT form a stable complex, and their binding interaction appears to mimic that of the CysK/CysE cysteine synthase complex. CdiA-CT activation is also required for growth inhibition. Synthesis of CdiA-CT in E. coli cysK(+) cells arrests cell growth, whereas the growth of ΔcysK mutants is unaffected by the toxin. Moreover, E. coli ΔcysK cells are completely resistant to inhibitor cells expressing UPEC536 CdiA, indicating that CysK is required to activate the tRNase during CDI. Thus, CysK acts as a permissive factor for CDI, providing a potential mechanism to modulate growth inhibition in target cells.
Insights
Bacterial contact-dependent growth inhibition (CDI) relies on CdiA-CT toxins. We discovered that the enzyme CysK activates these toxins, enabling bacterial growth inhibition and revealing a new regulatory mechanism for CDI.
Area of Science:
- Microbiology
- Bacterial Toxinology
- Molecular Biology
Background:
- Bacterial contact-dependent growth inhibition (CDI) uses CdiB/CdiA two-partner secretion systems.
- CdiA effectors deliver toxins (CdiA-CT) to target cells, while immunity proteins prevent self-toxicity.
Purpose of the Study:
- Investigate the activation mechanism of CdiA-CT from uropathogenic Escherichia coli (UPEC536).
- Determine the role of host factors in CdiA-CT activity and CDI.
Main Methods:
- In vitro biochemical assays to test CdiA-CT nuclease activity.
- Complex formation analysis between CdiA-CT and potential activators.
- Bacterial growth inhibition assays in wild-type and mutant Escherichia coli strains.
Main Results:
- UPEC536 CdiA-CT is a latent tRNase, inactive without a specific activator.
- Purified CysK (O-acetylserine sulfhydrylase A) activates CdiA-CT, enabling tRNA cleavage.
- CysK and CdiA-CT form a stable complex, mimicking CysK/CysE interactions.
- CysK is essential for CdiA-CT-mediated growth inhibition; ΔcysK mutants are resistant.
Conclusions:
- CysK acts as a crucial permissive factor for UPEC536 CdiA-CT activity.
- CysK-mediated activation of CdiA-CT is required for bacterial growth inhibition during CDI.
- This study uncovers a novel mechanism for regulating CDI efficacy through host enzyme interaction.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Positive Regulator Molecules
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

